Khalid El Bairi is the founder of The Cancer Biomarkers Working Group, Oujda, Morocco. He has published many peer-reviewed articles in the field of predictive and prognostic cancer biomarkers to improve survival outcomes in several WoS and Medline-indexed journals. His research focuses particularly on biomarkers for gynecological cancers such as ovarian cancer. He is currently a member of the board of various international scientific societies, and an editor and reviewer for more than 35 journals. He is also highly interested in teaching evidence-based medicine, clinical research methods, and publishing ethics to medical and PhD students.
Research Keywords & Expertise
Cancer Genetics
Gynecologic Oncology
Ovarian Cancer
Cancer Biomarkers
Clinical Oncology
Short Biography
Khalid El Bairi is the founder of The Cancer Biomarkers Working Group, Oujda, Morocco. He has published many peer-reviewed articles in the field of predictive and prognostic cancer biomarkers to improve survival outcomes in several WoS and Medline-indexed journals. His research focuses particularly on biomarkers for gynecological cancers such as ovarian cancer. He is currently a member of the board of various international scientific societies, and an editor and reviewer for more than 35 journals. He is also highly interested in teaching evidence-based medicine, clinical research methods, and publishing ethics to medical and PhD students.
Advance your academic career, collaborate globally, and expand your network—
join now
!
Well done!
